Skip to content
KLOW Index

A gunmetal data-console reading of the four-peptide KLOW research record — KPV, GHK-Cu, BPC-157 and TB-500 logged as four channels on one dense instrument panel, the component literature tabulated and the blend's missing combination data flagged as a null row.

FOUR PARTS // FOUR SETS OF STUDIES

What Did Each Part of the KLOW Stack Change?

KPV · GHK-Cu · BPC-157 · TB-500. The vial uses a 50/10/10/10 mg split, but no test has checked the mix.

What stays separate in the vial?

When you read KLOW stack, think of four small protein pieces. Adding water doesn't turn them into one new drug.

GHK-Cu supplies 50 of the 80 mg. BPC-157, TB-500, and KPV each supply 10 mg.

Here's the catch. Each finding below came from one part tested by itself.

You don't have a test of the four-part stack as one treatment. Separate work can't tell you how the vial will affect you.

What did KPV change in sore bowels (10 mg)?

KPV is the last three building blocks of a natural hormone. That hormone comes from the pituitary gland, the small gland below your brain that helps run growth and other body jobs.

The full hormone has thirteen building blocks. It helps control swelling and skin color, while KPV is only one short piece.

What changed in cells: KPV lowered signs that keep swelling going. The test used human bowel and immune cells kept alive in lab dishes [3].

A carrier in the bowel pulls small protein pieces into cells. Sore bowel tissue had more of that carrier, so KPV may enter the sore spots more easily [3].

What happened in mice: Mice drank KPV at 100 micromoles. A micromole is a lab count of tiny bits, not a dose worked out for people.

The mice had less swelling in their sore colons [3][9]. Fewer immune cells also crowded into the bowel.

A close cousin of KPV helped the bowel wall keep harmful matter out [10]. In another mouse test, KPV entered bowel cells and the mice grew fewer tumors tied to long-term swelling [11].

What hasn't been shown: KPV has no approved use in people. You have human work mainly on ways to get KPV into the bowel.

A mouse result can't settle what happens in your bowel. One swelling sign in the papers was called IL-6.

What did KPV change in sore bowels (10 mg)?

What did GHK-Cu change in skin and tissue (50 mg)?

GHK-Cu joins three protein building blocks to copper. It was first found in human blood in 1973.

GHK-Cu blood levels drop from about 200 billionths of a gram per milliliter at age 20 to about 80 billionths by age 60 [4].

What changed in cells: A dish test used 1-10 nanomoles, a lab count of bits too small to see. Researchers counted a DNA instruction only when its work changed by ≥50%.

Of the changed instructions, 59% became more active and 41% became less active [5]. Many dealt with mending tissue, guarding cells, and fixing DNA.

The paper used the same ≥50% rule for its firm count. About 2,100 DNA instructions met that rule, so the common claim of ~4,000 is only a guess.

What cells made: Cells made more collagen and other tissue material after GHK-Cu. Collagen is the protein that gives skin and tendons strength.

The copper also helps join collagen to elastin, the stretchy protein in skin and blood vessels [4]. Those two proteins help tissue stay strong and spring back.

What happened on skin: A GHK-Cu cream raised collagen in 70% of treated women. The same review found 50% for vitamin C and 40% for a vitamin A cream [4].

People have used GHK-Cu on skin and wounds for years. It has no approved use as a treatment for the whole body.

What happened in rats [12][13]: GHK eased fear-like acts in one test [13]. It also cut fights caused by pain in another [12].

Those rat findings don't prove tissue repair in you. You can't treat a skin-cream result as proof either.

GHK-Cu is described as a 1:1 mix. That means 1 copper part for each peptide part.

What did BPC-157 change in rat tendons and guts (10 mg)?

BPC-157 means Body Protection Compound 157. It's a man-made peptide with fifteen protein building blocks, based on a protein found in stomach juice.

What may help repair: BPC-157 changed rat tendon cells in ways that may grow new blood vessels. It also changed how those cells used nitric oxide, a gas the body makes to widen blood vessels [2].

More open blood vessels may help blood reach a wound. You can't treat that rat-cell idea as a finding in people.

What happened to tendons [2]: Researchers fully cut the rats' Achilles tendons. BPC 157 helped them mend faster, bear more weight, and move better.

The tendon tissue also looked more healed, and tendon cells spread faster in a lab dish. Tests put 10 millionths, 10 billionths, or 10 trillionths of a gram into each rat's belly.

What happened to stomach ulcers [8]: Rats got 400-800 billionths of a gram per kilogram into muscle. Ulcer growth fell by 45.7-65.6%, and the stomach lining grew back faster.

What newer work found:

  • A 2024 rat test found that a hole between two bowel parts closed faster [14].
  • A 2024 report covered a dozen people with painful bladders. Symptoms ended in 10/12, and all rated the result 5/5 [15].
  • That bladder report had no group getting other care. No bad events were seen.
  • In 2025, two healthy adults received up to 20 mg through a vein. Heart, liver, kidney, thyroid, and sugar tests showed no clear harm [6].

What the law means: BPC-157 isn't FDA-approved. Federal reviewers placed it in category 2, which doesn't approve it as a drug or clear it for routine pharmacy mixing.

You still need more safety facts before that status could change. A rat tendon still can't answer what happens to your tendon.

The paper also names cell docking spot 2, where a cell takes in a message. The bladder report covered 12 people.

What might TB-500 change in wound repair (10 mg)?

TB-500 is a man-made piece of a natural body protein called beta-4. It copies one short part from that larger protein.

For you, the short piece's public tracking number is missing. You can't use that missing number to judge purity.

What the short piece may do: TB-500 binds to a protein that helps a cell hold its shape and move. That may help cells spread across a wound.

The whole natural protein does other work too. Tests haven't shown that short TB-500 can do those jobs [7].

What happened in the main wound test [1]: Rats had deep skin wounds. The whole natural protein raised new skin growth by 42% at day 4 and 61% at day 7 versus salt water.

Wounds drew together by ≥11% at day 7. The rats also made more collagen and blood vessels.

Just 10 trillionths of a gram helped skin cells move 2–3-fold in a lab dish. The test used the whole protein, not the short piece [1].

What a 2026 review found [7]: Animal results for the short peptide, beta-4, and BPC-157 looked hopeful. The review found little safety work in people.

The authors also warned of grave harm and weak public control. Hopeful animal work isn't a safety finding for you.

What the sports rule means: The World Anti-Doping Agency writes the drug rules for world sport. Its banned list names the whole natural protein, beta-4.

The rule applies both during and outside a contest. TB-500 may be covered, so tested athletes must treat KLOW as off-limits.

The papers also call the whole protein beta-4. A result for that protein isn't proof for your short peptide.

What does KLOW add to GLOW?

KLOW and GLOW have different contents. GLOW has GHK-Cu, BPC-157, and TB-500, while KLOW adds 10 mg of KPV.

KPV may calm cell steps that keep bowel swelling going. A bowel carrier helps move KPV into sore cells [3].

Some research users say KLOW eased swelling more than GLOW. That's a personal report, not a finding from a study that checked the two blends.

You don't get a settled choice from the extra part. Another person's report can't predict your result.